SCHEMBL2844978

SCHEMBL2844978

CC(C)(C)OC(=O)N1CC(CO[Si](C)(C)C(C)(C)C)C[C@H]1COc1c(F)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 4/20 0.43
TOP2A P11388 6/20 0.41
TOP2B Q02880 6/20 0.41
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 2/20 0.41
POLB P06746 1/20 0.41
PRKD3 O94806 1/20 0.41
ALOX15 P16050 1/20 0.41
OPRM1 P35372 1/20 0.41
CLK2 P49760 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
GSK3B P49841 1/20 0.40
ATM Q13315 1/20 0.39
LMNA P02545 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL584330 1.00 KCNH2 (0.43) KCNH2TOP2ATOP2BKDM4EALDH1A1
SCHEMBL584991 1.00 KCNH2 (0.43) KCNH2TOP2ATOP2BKDM4EALDH1A1
SCHEMBL584819 0.92 ADRB2 (0.43) KCNH2TOP2ATOP2BKDM4EALDH1A1
SCHEMBL584190 0.92 ADRB2 (0.43) KCNH2TOP2ATOP2BKDM4EALDH1A1
SCHEMBL3054226 0.92 ADRB2 (0.43) KCNH2TOP2ATOP2BKDM4EALDH1A1
SCHEMBL585466 0.90 STAT3 (0.39) KCNH2TOP2ATOP2BKDM4EALDH1A1
SCHEMBL595858 0.90 STAT3 (0.39) KCNH2TOP2ATOP2BKDM4EALDH1A1
SCHEMBL2847602 0.90 STAT3 (0.39) KCNH2TOP2ATOP2BKDM4EALDH1A1
SCHEMBL2844980 0.82 KCNH2 (0.43) KCNH2TOP2ATOP2BKDM4EALDH1A1
SCHEMBL584331 0.82 KCNH2 (0.43) KCNH2TOP2ATOP2BKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2256120-A1 Oxazolidinone-quinolone hybrids as antibacterial compounds Actelion Pharmaceuticals Ltd. (CH) 2010-12-01 EP disclosed